Functional selectivity and time‐dependence of μ‐opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area
Background and Purpose The majority of studies examining desensitization of the μ‐opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist‐induce...
Saved in:
Published in | British journal of pharmacology Vol. 172; no. 2; pp. 469 - 481 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background and Purpose
The majority of studies examining desensitization of the μ‐opioid receptor (MOR) have examined those located at cell bodies. However, MORs are extensively expressed at nerve terminals throughout the mammalian nervous system. This study is designed to investigate agonist‐induced MOR desensitization at nerve terminals in the mouse ventral tegmental area (VTA).
Experimental Approach
MOR function was measured in mature mouse brain slices containing the VTA using whole‐cell patch‐clamp electrophysiology. Presynaptic MOR function was isolated from postsynaptic function and the functional selectivity, time‐dependence and mechanisms of agonist‐induced MOR desensitization were examined.
Key Results
MORs located at GABAergic nerve terminals in the VTA were completely resistant to rapid desensitization induced by the high‐efficacy agonists DAMGO and Met‐enkephalin. MORs located postsynaptically on GABAergic cell bodies readily underwent rapid desensitization in response to DAMGO. However, after prolonged (>7 h) treatment with Met‐enkephalin, profound homologous MOR desensitization was observed. Morphine could induce rapid MOR desensitization at nerve terminals when PKC was activated.
Conclusions and Implications
Agonist‐induced MOR desensitization in GABAergic neurons in the VTA is compartment‐selective as well as agonist‐selective. When MORs are located at cell bodies, higher‐efficacy agonists induce greater levels of rapid desensitization than lower‐efficacy agonists. However, the converse is true at nerve terminals where agonists that induce MOR desensitization via PKC are capable of rapid agonist‐induced desensitization while higher‐efficacy agonists are not. MOR desensitization induced by higher‐efficacy agonists at nerve terminals only takes place after prolonged receptor activation.
Linked Articles
This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2 |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0007-1188 1476-5381 |
DOI: | 10.1111/bph.12605 |